BC
Broadfin Capital Portfolio holdings
AUM
$403M
1-Year Return
74.97%
This Quarter Return
+22.65%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.03B
AUM Growth
+$274M
(+36%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
15.07%
Top 10 Holdings %
Top 10 Hldgs %
40.17%
Holding
97
New
37
Increased
20
Reduced
20
Closed
12
Top Buys
| 1 |
Travere Therapeutics
TVTX
|
$34.1M |
| 2 |
Heron Therapeutics
HRTX
|
$31.1M |
| 3 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$21M |
| 4 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$20.1M |
| 5 |
Emergent Biosolutions
EBS
|
$18.5M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$29.1M |
| 2 |
LCI
Lannett Company, Inc.
LCI
|
$23.4M |
| 3 |
Assertio
ASRT
|
$22.5M |
| 4 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$16.6M |
| 5 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
$14.9M |
Sector Composition
| 1 | Healthcare | 79.95% |
| 2 | Technology | 0.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Carisma Therapeutics
CARM
$16.8M
| $14M | 1.36% |
+43,097
| New | +$14M |
|
27
Dynavax Technologies
DVAX
$1.18B
| $13.8M | 1.34% |
766,010
+41,010
| +6% | +$741K |
|
28
AtriCure
ATRC
$1.76B
| $13.4M | 1.3% |
712,495
+275,000
| +63% | +$5.17M |
|
|
ACGN
29
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $13.1M | 1.27% |
23,558
-2,571
| -10% | -$1.43M |
|
|
ELOS
30
DELISTED
Syneron Medical Ltd
ELOS
| $12.5M | 1.21% |
1,005,221
+805,221
| +403% | +$10M |
|
|
PETX
31
DELISTED
Aratana Therapeutics, Inc.
PETX
| $12.4M | 1.2% |
+667,435
| New | +$12.4M |
|
|
LBMH
32
DELISTED
LIBERATOR MED HLDGS INC (NY)
LBMH
| $12M | 1.16% |
3,058,644
+889,113
| +41% | +$3.49M |
|
|
AUXL
33
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $11.2M | 1.08% |
411,100
-550,000
| -57% | -$14.9M |
|
|
CEMP
34
DELISTED
Cempra, Inc.
CEMP
| $11M | 1.07% |
955,147
-209,400
| -18% | -$2.42M |
|
|
OCR
35
DELISTED
OMNICARE INC
OCR
| $10.4M | 1.01% |
+175,000
| New | +$10.4M |
|
36
Molina Healthcare
MOH
$9.47B
| $10.3M | 1% |
275,000
+45,700
| +20% | +$1.72M |
|
37
Xencor
XNCR
$610M
| $9.09M | 0.88% |
774,881
-99,119
| -11% | -$1.16M |
|
|
SGNT
38
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $8.89M | 0.86% |
380,188
+58,800
| +18% | +$1.37M |
|
|
POZN
39
DELISTED
POZEN INC
POZN
| $8.67M | 0.84% |
1,083,087
-72,236
| -6% | -$578K |
|
|
TLGT
40
DELISTED
Teligent, Inc
TLGT
| $8.48M | 0.82% |
150,000
| – | – |
|
|
ATRS
41
DELISTED
Antares Pharma, Inc.
ATRS
| $8.05M | 0.78% |
2,300,000
+1,500,000
| +188% | +$5.25M |
|
|
CCXI
42
DELISTED
ChemoCentryx, Inc.
CCXI
| $6.96M | 0.67% |
1,050,000
+16,332
| +2% | +$108K |
|
43
Neurogene
NGNE
$285M
| $6.5M | 0.63% |
+25,525
| New | +$6.5M |
|
|
UAM
44
DELISTED
Universal American Corp
UAM
| $6.23M | 0.6% |
+881,605
| New | +$6.23M |
|
45
DURECT Corp
DRRX
$59.3M
| $5.86M | 0.57% |
440,450
-103,579
| -19% | -$1.38M |
|
46
Tenax Therapeutics
TENX
$27.4M
| $5.51M | 0.53% |
+31
| New | +$5.51M |
|
|
AIRM
47
DELISTED
Air Methods Corp
AIRM
| $5.34M | 0.52% |
+100,000
| New | +$5.34M |
|
|
RXDX
48
DELISTED
Ignyta, Inc.
RXDX
| $5.33M | 0.52% |
+641,700
| New | +$5.33M |
|
|
NSTG
49
DELISTED
NanoString Technologies, Inc.
NSTG
| $5.25M | 0.51% |
+254,068
| New | +$5.25M |
|
50
Tonix Pharmaceuticals
TNXP
$233M
| – | – |
0
| – | -$4.05M |
|